Table 1 Effectiveness of perioperative intraperitoneal chemotherapy (PIC) for peritoneal carcinomatosis arising from the appendix (pseudomyxoma peritonei)
Chief-Investigator | PIC | n | Median follow-up (months) | Overall survival (%) | Disease-free survival (%) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | 1Â year | 3Â years | 5Â years | 10Â years | 1Â year | 3Â years | 5Â years |
Sugarbaker [5] | HIPEC or EPIC (MMC) | 501 | 48 | --- | --- | 71.9 | 54.5 | --- | --- | --- |
Elias [11] | HIPEC (OX or MMC) | 301 | 88 | --- | --- | 73 | --- | --- | --- | 56 |
Moran [12] | HIPEC (MMC) | 289 | 39 | --- | --- | 87 | 74 | --- | --- | 70 |
Choudry [15] | HIPEC (MMC) | 282 | 24 | --- | 67.4 | 52.7 | --- | --- | 45.1 | 32.1 |
Morris [6] | HIPEC (MMC) | 106 | 23 | --- | --- | 75 | --- | 71 | 51 | 38 |
Deraco [10] | HIPEC (MMC) | 104 | 37 | --- | --- | 71.9 | --- | --- | --- | 38.8 |
Zoetmulder [8] | HIPEC (MMC) | 103 | 51.5 | 90 | 70.9 | 59.5 | >50 | --- | 43.6 | 37.4 |
Sardi (PMCA) [14] | HIPEC (MMC) | 77 | 18 | 88 | 56 | 40 | --- | --- | --- | --- |
Temple [13] | HIPEC (MMC) | 58 | 28 | --- | 76 | 62 | --- | --- | 48 | 42 |
Current study | HIPEC (OX) | 58 | 29.1 | --- | --- | 66.2 | --- | --- | --- | 50 |